Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study

• Published in: Geburtshilfe und Frauenheilkunde
• Main Authors: Hack, CC, Fasching, PA, Fehm, T, de Waal, J, Rezai, M, Baier, B, Baake, G, Kolberg, HC, Guggenberger, M, Warm, M, Harbeck, N, Wuerstlein, R, Deuker, JU, Dall, P, Richter, B, Wachsmann, G, Brucker, C, Siebers, JW, Fersis, N, Kuhn, T, Wolf, C, Vollert, HW, Breitbach, GP, Janni, W, Landthaler, R, Kohls, A, Rezek, D, Noesselt, T, Fischer, G, Henschen, S, Praetz, T, Heyl, V, Kühn, T, Krauß, T, Thomssen, C, Hohn, A, Tesch, H, Mundhenke, C, Hein, A, Rauh, C, Bayer, CM, Jacob, A, Schmidt, K, Belleville, E, Hadji, P, Brucker, SY, Wallwiener, D, Paepke, D, Kümmel, S, Beckmann, MW
• Format: Conference Proceeding
• Language: English
• Published: 13.10.2016
• ISSN: 0016-5751; 1438-8804
• DOI: 10.1055/s-0036-1593261

Background: Breast cancer patients make frequent use of complementary and alternative medicine (CAM), but few prospectively collected data are available specifically for postmenopausal breast cancer patients receiving adjuvant antihormonal therapy. The aim of the study was to identify the characteristics of patients who are interested in integrative medicine (IM). Methods: The EvAluate-TM study is a prospective noninterventional study, in which treatment with letrozole was evaluated in postmenopausal women with hormone receptor-positive primary breast cancer. 5,045 patients were enrolled at 339 certified breast centers. As part of the data collection process, patients were asked at the baseline about their interest in and information needs about IM. Results: 3,411 patients responded to the questionnaire on IM and took part in the analysis. 1,583 patients expressed an interest in IM. Relevant predictors of interest in IM were age, body mass index, tumor size, previous chemotherapy, and use of concomitant medications for other medical conditions. Interest in IM declined highly significantly (P < 0.001) with age. In addition, these women were mostly interested in receiving information about their disease from a physician. Conclusions: This study shows that postmenopausal women have a strong interest in IM. Information about IM should therefore be included in patient care for this patient group. Especially the patients receiving concomitant medication, which is one of the main predictors for women not being interested in IM, may need special attention. In addition, most patients were interested in obtaining the relevant information from their doctor, indicating that responsibility for this lies with the treating physicians.